Replimune Group, Inc. (REPL)
8.41
+0.80
(+10.51%)
USD |
NASDAQ |
Apr 02, 16:00
8.42
+0.01
(+0.12%)
Pre-Market: 20:00
Replimune Group Total Liabilities (Quarterly) : 123.05M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 899.65M |
| Phathom Pharmaceuticals, Inc. | 697.97M |
| REGENXBIO, Inc. | 350.30M |
| Corcept Therapeutics, Inc. | 190.22M |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 333.59M |
| Shareholders Equity (Quarterly) | 210.54M |
| Debt to Equity Ratio | 0.3626 |
| Current Ratio | 5.597 |
| Net Debt Paydown Yield | -0.01% |